Compounds > betulinic acid

betulinic acid and HIV Coinfection

betulinic acid has been researched along with HIV Coinfection in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (16.67)18.2507
2000's2 (33.33)29.6817
2010's3 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Nantasenamat, C; Prachayasittikul, V; Prapojanasomboon, J; Siriwong, S; Toropov, AA; Toropova, AP; Worachartcheewan, A1
Bellampalli, SS; Cai, S; Chefdeville, A; Chew, LA; Dorame, A; Gandini, MA; Gunatilaka, AAL; Ji, Y; Khanna, M; Khanna, R; Luo, S; Madura, CL; Molnar, G; Moutal, A; Streicher, JM; Wijeratne, EMK; Yu, J; Zamponi, GW1
Chen, WH; Jiang, S; Jiang, ZH; Ke, Z; Liu, S; Liu, Y; Wu, KY1
Cichewicz, RH; Kouzi, SA1
Allaway, GP; Chen, CH; Lee, KH; Martin, DE; Morris-Natschke, SL; Wild, CT; Yu, D1
Bousseau, A; De Clercq, E; Dereu, N; Evers, M; Hénin, Y; Huet, T; Mayaux, JF; Pauwels, R; Poujade, C; Soler, F1

Reviews

2 review(s) available for betulinic acid and HIV Coinfection

ArticleYear
Chemistry, biological activity, and chemotherapeutic potential of betulinic acid for the prevention and treatment of cancer and HIV infection.
    Medicinal research reviews, 2004, Volume: 24, Issue:1

    Topics: Animals; Anti-HIV Agents; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents, Phytogenic; Betulinic Acid; HIV Infections; Humans; Mass Spectrometry; Neoplasms; Pentacyclic Triterpenes; Triterpenes

2004
The discovery of a class of novel HIV-1 maturation inhibitors and their potential in the therapy of HIV.
    Expert opinion on investigational drugs, 2005, Volume: 14, Issue:6

    Topics: Animals; Anti-HIV Agents; Betulinic Acid; Drugs, Investigational; HIV Infections; HIV-1; Humans; Pentacyclic Triterpenes; Triterpenes

2005

Other Studies

4 other study(ies) available for betulinic acid and HIV Coinfection

ArticleYear
Quantitative Structure-activity Relationship Study of Betulinic Acid Derivatives Against HIV using SMILES-based Descriptors.
    Current computer-aided drug design, 2018, Volume: 14, Issue:2

    Topics: Anti-HIV Agents; Betulinic Acid; Cell Line; Drug Discovery; HIV; HIV Infections; Humans; Pentacyclic Triterpenes; Quantitative Structure-Activity Relationship; Software; Triterpenes

2018
Betulinic acid, derived from the desert lavender Hyptis emoryi, attenuates paclitaxel-, HIV-, and nerve injury-associated peripheral sensory neuropathy via block of N- and T-type calcium channels.
    Pain, 2019, Volume: 160, Issue:1

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Betulinic Acid; Calcium Channels, N-Type; Calcium Channels, T-Type; CHO Cells; Cricetulus; Diprenorphine; Disease Models, Animal; Female; Ganglia, Spinal; HIV Infections; Inhibitory Postsynaptic Potentials; Male; Mice; Mice, Inbred C57BL; Neuralgia; Neurons; Paclitaxel; Pentacyclic Triterpenes; Peripheral Nerve Injuries; Rats; Rats, Sprague-Dawley; Triterpenes; Tritium

2019
An amphiphilic conjugate approach toward the design and synthesis of betulinic acid-polyphenol conjugates as inhibitors of the HIV-1 gp41 fusion core formation.
    ChemMedChem, 2011, Sep-05, Volume: 6, Issue:9

    Topics: Algorithms; Betulinic Acid; Dose-Response Relationship, Drug; Drug Design; HIV Envelope Protein gp41; HIV Fusion Inhibitors; HIV Infections; Humans; Hydrogen Bonding; Hydrophobic and Hydrophilic Interactions; Models, Molecular; Pentacyclic Triterpenes; Polyphenols; Triterpenes

2011
Triterpene derivatives that block entry of human immunodeficiency virus type 1 into cells.
    Proceedings of the National Academy of Sciences of the United States of America, 1994, Apr-26, Volume: 91, Issue:9

    Topics: Antiviral Agents; Betulinic Acid; CD4 Antigens; Cell Line; HIV Infections; HIV-1; Membrane Fusion; Pentacyclic Triterpenes; Structure-Activity Relationship; Triterpenes

1994